NanoGuardian launches Web resource to fight RX counterfeiting

SKOKIE, Ill. A company that markets technology for preventing diversion and counterfeiting of drugs has launched a Web site to provide information and resources to help combat the problem.

NanoGuardian, a division of NanoInk, provides information on the company’s brand-protection technology, NanoEncryption, and its market-monitoring program, Closed-Loop Protection.

“The new NanoGuardian Web site is a resource for those in government, law enforcement and any industry that is affected by illegal counterfeiting and diversion of its products,” NanoGuardian executive vice president Dean Hart said in a statement. “We also encourage visitors to learn about our novel NanoEncryption technology, which is the only on-dose, multi-layered brand-protection solution that enables pharmaceutical manufacturers to trace and authenticate every single dose from plant to patient.”